|
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease
|
Jan 2018
|
Biology of Blood and Marrow Transportation
|
graft versus host disease (GVHD)
|
|
Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia
|
May 2017
|
Blood
|
acute myeloid leukemia (AML)
|
|
Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen
|
Feb 2013
|
Clin Transplant
|
aplastic anemia
|
|
Epidemiology and risk factors for infections in myelodysplastic syndromes.
|
Sep 2013
|
Transpl Infect Dis
|
myelodysplastic syndromes (MDS)
|
|
Epidemiology of myelodysplastic syndromes
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia
|
Apr 2021
|
Transplantation and Cellular Therapy
|
aplastic anemia, graft versus host disease (GVHD)
|
|
Epigenetic alterations and microRNAs: New players in the pathogenesis of myelodysplastic syndromes.
|
May 2013
|
Epigenetics
|
myelodysplastic syndromes (MDS)
|
|
Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes
|
Aug 2014
|
Epigenomics
|
myelodysplastic syndromes (MDS)
|
|
Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents
|
Jul 2013
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
Epigenetics of myelodysplastic syndromes
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
